Results 11 to 20 of about 480,558 (290)

Alpha-1 antitrypsin deficiency [PDF]

open access: yesRespiratory Medicine CME, 2010
To review the topic of alpha-1 antitrypsin (AAT) deficiency.Narrative literature review.Much work has been carried out on this condition with many questions being answered but still further questions remain.AAT deficiency is an autosomal co-dominantly inherited disease which affects the lungs and liver predominantly.
Kelly, Emer   +4 more
openaire   +5 more sources

A Review of Alpha-1 Antitrypsin Binding Partners for Immune Regulation and Potential Therapeutic Application

open access: yesInternational Journal of Molecular Sciences, 2022
Alpha-1 antitrypsin (AAT) is the canonical serine protease inhibitor of neutrophil-derived proteases and can modulate innate immune mechanisms through its anti-inflammatory activities mediated by a broad spectrum of protein, cytokine, and cell surface ...
M. E. O'Brien   +9 more
semanticscholar   +1 more source

Expert Perspectives on the Management of Alpha 1-Antitrypsin Deficiency

open access: yesActa Médica Portuguesa, 2022
Alpha 1-antitrypsin deficiency is an inherited autosomal codominant disorder, which predisposes patients to lung and/or liver disease. Even though it is considered rare, it is one of the most frequent genetic disorders worldwide, albeit remaining ...
Bebiana Conde   +9 more
doaj   +1 more source

Known Mutations at the Cause of Alpha-1 Antitrypsin Deficiency an Updated Overview of SERPINA1 Variation Spectrum

open access: yesThe Application of Clinical Genetics, 2021
Alpha-1-Antitrypsin deficiency (AATD), caused by SERPINA1 mutations, is one of the most prevalent Mendelian disorders among individuals of European descend.
S. Seixas, P. Marques
semanticscholar   +1 more source

Evaluation of Cytosine Base Editing and Adenine Base Editing as a Potential Treatment for Alpha-1 Antitrypsin Deficiency.

open access: yesMolecular Therapy, 2022
Alpha-1 Antitrypsin Deficiency (AATD) is a rare autosomal codominant disease caused by mutations within the SERPINA1 gene. The most prevalent variant in patients is PiZ SERPINA1 containing a single G>A transition mutation.
M. Packer   +14 more
semanticscholar   +1 more source

Hepatobiliary phenotypes of adults with alpha-1 antitrypsin deficiency

open access: yesGut, 2021
Objective Alpha-1 antitrypsin deficiency (AATD) is a common, potentially lethal inborn disorder caused by mutations in alpha-1 antitrypsin (AAT).
M. Fromme   +43 more
semanticscholar   +1 more source

Alpha-1 antitrypsin inhibits TMPRSS2 protease activity and SARS-CoV-2 infection

open access: yesNature Communications, 2021
SARS-CoV-2 is a respiratory pathogen and primarily infects the airway epithelium. As our knowledge about innate immune factors of the respiratory tract against SARS-CoV-2 is limited, we generated and screened a peptide/protein library derived from ...
Lukas Wettstein   +29 more
semanticscholar   +1 more source

Association of alpha-1 antitrypsin level and lung function in patients with chronic obstructive pulmonary disease [PDF]

open access: yesSrpski Arhiv za Celokupno Lekarstvo, 2017
Introduction/Objective. Alpha-1 antitrypsin deficiency is a well established inherited risk factor for chronic obstructive pulmonary disease (COPD); however, alpha-1 antitrypsin level may result in different lung function reduction.
Serapinas Danielius   +5 more
doaj   +1 more source

Alpha-1 Antitrypsin Deficiency Associated Panniculitis.

open access: yesJournal of American Academy of Dermatology, 2021
BACKGROUND Panniculitis represents a rare and potentially lethal manifestation of alpha-1 antitrypsin deficiency (AATD). Evidence regarding management is limited to case reports and small case series.
A. Franciosi   +7 more
semanticscholar   +1 more source

The impact of diagnostic delay on survival in alpha-1-antitrypsin deficiency: results from the Austrian Alpha-1 Lung Registry

open access: yesRespiratory Research, 2023
Background Alpha-1-antitrypsin (AAT) deficiency (AATD) is a genetic disorder that can manifest as lung disease. A delay between onset of symptoms and diagnosis of AATD is common and associated with worse clinical status and more advanced disease stage ...
Tobias Meischl   +12 more
doaj   +1 more source

Home - About - Disclaimer - Privacy